Characteristics | Frequency | IPTp-SP uptake | Chi-square | p value | |
---|---|---|---|---|---|
n = 212(%) | < 3 doses n = 22 (%) | ≥3 doses n = 190 (%) | |||
Educational level | |||||
No formal education | 23 (10.8) | 8 (34.8) | 15 (65.2) | 16.522 | < 0.001 |
Formal education | 189 (89.2) | 14 (7.4) | 175 (92.6) | ||
Gestational age at first ANC | |||||
First trimester | 91 (42.9) | 8 (8.8) | 83 (39.6) | 13.405 | < 0.001 |
Second trimester | 109 (51.4) | 9 (8.3) | 100 (91.7) | ||
Third trimester | 12 (5.7) | 5 (41.7) | 7 (58.3) | ||
Gestational age at first dose of SP | |||||
Second trimester | 194 (91.5) | 16 (8.3) | 178 (91.7) | 11.14 | 0.001 |
Third trimester | 18 (8.5) | 6 (33.3) | 12 (66.7) | ||
Side effects of SP | |||||
Side effects | 115 (54.3) | 7 (6.1) | 108 (93.9) | 4.975 | 0.026 |
No side effects | 97 (45.7) | 15 (15.5) | 82 (84.5) | ||
Reason for IPTp-SP | |||||
Malaria prevention | 171 (80.7) | 15 (8.8) | 156 (91.2) | 2.450 | 0.117 |
Do not know | 41 (19.3) | 7 (17.1) | 34 (82.9) | ||
Interval between SP doses | |||||
Monthly | 188 (88.7) | 16 (8.5) | 172 (91.5) | 6.222 | 0.013 |
Does not know | 24 (11.3) | 6 (25.0) | 18 (75.0) | ||
Number of ANC visits | |||||
≥ 4 | 188 (66.5) | 6 (3.2) | 182 (96.8) | 92.201 | < 0.001 |
< 4 | 24 (33.5) | 16 (66.7) | 8 (33.3) |